Vitamin D3, vitamin K2, and warfarin regulate bone metabolism in human paranasal sinus bones

Rhinology

Volumn 45, Issue 3, 2007, Pages 208-213

  Sugimoto, Ichiro ^a   Hirakawa, Katsuhiro ^a   Ishino, Takashi ^a   Takeno, Sachio ^a   Yajin, Koji ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Osteoblast; TGF ; Vitamin D3; Vitamin K2; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; COLECALCIFEROL; CYTOKINE; FARNOQUINONE; WARFARIN;

ADULT; AGED; ARTICLE; BONE MINERALIZATION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FACIAL BONE; FEMALE; HUMAN; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED; OSTEOBLAST; PARANASAL SINUS;

ADULT; AGED; ANTICOAGULANTS; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; CHOLECALCIFEROL; CYTOKINES; FACIAL BONES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; PARANASAL SINUSES; VITAMIN K 2; WARFARIN;

EID: 35148837518     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kennedy DW, Senior BA, Gannon FH, Montone KT, Hwang P, Lanza DC. Histology and histomorphometry ethmoid bone in chronic rhinosinusitis. Laryngoscope 1998; 108: 502-507.
2. Khalid AN, Hunt J, Perloff JR, Kennedy DW. The role of bone in chronic rhinosinusitis. Laryngoscope 2002; 112: 1951-1957.
3. Kassem M, Harris SA, Spelsberg TC, Riggs BL. Estrogen inhibits interleukin-6 production and gene expression in human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res 1996; 11: 193-199.
4. Kim CH, Kim HK, Shong YK, Lee KU, Kim GS. Thyroid hormone stimulates basal and interleukin (IL)-1-induced IL-6 production in human bone marrow stromal cells: a possible mediator of thyroid hormone-induced bone loss. J Endocrinol 1999; 160: 97-102.
5. Lisignoli G, Toneguzzi S, Pozzi C et al. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1999; 26: 791-799.
6. Chenoufi HL, Diamant M, Rieneck K, Lund B, Stein GS, Lian JB. Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone. J Cell Biochem 2001; 81: 666-678.
7. Beresford JN, Gallagher JA, Russell RG. 1,25-Dihydroxyvitamin D3 and human bone-derived cell in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology 1986; 119: 1776-1785.
8. Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro J bone Miner Res 1997; 12: 431-438.
9. Miyake N, Hoshi K, Sano Y, Kikuchi K, Koshihara Y. 1,25-Dihydroxyviamin D3 promotes vitamin K2 metabolism in human osteoblast. Osteoporos Int 2001; 12: 680-687.
10. Beresford JN, Joyner CJ, Devlin C, Triffitt JT. The effects of dexamethasone and 1, 25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch oral Biol 1994; 39: 941-947.
11. Anderson JJ, Rondano P, Holmes A. Role of diet and physical activity in the prevention of osteoporosis. Scand J Rheumatol Suppl 1996; 103: 69-74.
12. Weber P. The role of vitamin in the prevention of osteoporosis abrief status report. Int J Vitam Nutr Res 1999; 69: 194-197.
13. Kassem M, Kveiborg M, Eriksen EF. Production and action of transforming growth factor-β in human osteoblast culture: dependence on cell differentiation and modulation by calcitriol. Eur J Clird Invest 2000; 30: 429-437.
14. Torricelli P, Fini M, Giavaresi G, Giardino R. Human osteoblast cultures from osteoporotic and healty bone: biochemical markers and cytokine expression in basal conditions and in response to 1,25(OH)2D3. Artif Cells Blood Substit Immobil Biotechnol 2002; 30: 219-227.
15. Yamaguchi M, Uchiyama S, Tsukamoto Y. Stimulatory effect of menaquione-7 on bone formation in elderly female rat femoral tissues in vitro: prevention of bone deterioration with aging. Int Mol Med 2002; 10: 729-733.
16. Ishino T, Yajin K, Takeno S, Furukido K, Hirakawa K. Establishment of osteoblast culture from human ethmoidal sinus. Auris Nasus Larynx 2003; 30: 45-51.
17. Koshihara Y, Hoshi K, Ishibashi, Shiraki M. Vitamin K2 Promotes 1,25(OH)2 Vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int 1996; 59: 466-473.
18. Weber P. Management of osteoporosis: is there a role for vitamin K? Int J Vitam Nutr Res 1997; 67: 350-356.
19. Shearer MJ. Vitamin K. Lancet 1995; 345: 229-234.
20. Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Annu Rev Nutr 1995; 15: 1-22.
21. Choi JY, Lee BH, Song KB et al. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T-E1 cells. J Cell Biochern 1996; 61: 609-618.
22. Seydin. SM, Thompson AY, Bentz H et al. Cartigalage-inducing factor-A: Apparet identity to transforming growth factor-beta. J Biol Chem 1986; 261: 5693-5695.
23. Luo XH, Liao EY, Su X. Progesteron upregulates TGF-β isoforms (β1, β2, and β3) expression in normal human osteoblast-like cells. Calcif Tissue Int 2002; 71: 329-334.
24. Serpero L, Petecchia L, Sabatini F et al. The effect of transforming growth factor (TGF)-betal and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett. 2006; 105: 61-67.
25. Miller DA, Pelton RW, Derynck R, Moses HL. Transforming growth factor-beta. A family of growth regulatory peptides. Ann N Y Acad Sci 1990; 593: 208-217.
26. Bismar H, Klöppinger T, Schster EM et al. Transforming growth factor beta (TGF-beta) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-beta in human bone matrix in vivo. Bone 1999; 24: 565-569.
27. Zhang H, Ahmad M, Gronowicz G. Effects of transforming growth factor-beta 1 (TGF-beta 1) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials 2003; 24: 2013-2020.
28. Joyce ME, Roberts AB, Sporm MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol.1990; 110: 2195-2207.
29. Horner A, Kemp P, Summers C et al. Expression and distribution of transforming growth factor-beta isoforms and their singnaling receptors in growing human bone. Bone 1998; 23: 95-102.
30. Franchimont N, Rydziel S, Canalis E. Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest 1997; 100: 1797-1803.
31. Grey A, Mitnick MA, Masiukiewicz U et al. A Role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 1999; 140: 4683-4690.
32. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003; 32: 1-7.
33. Tran JM, Kleeman CR, Green J. Production of interleukin-6 by osteoblastic cell is independent of medium inorganic phosphate. Biochem Mol Med 1995; 55: 90-95.
34. Kozawa O, Tokuda H, Kaida T, Matsuno H, Uematsu T. Effect of vitamin D3 on interleukin-6 synthesis induced by prostaglandins in osteoblasts. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 119-123.
35. Gruber R, Nothegger G, Ho G, Willheim M, Peterlik M. Differential stimulation by PGE(2) and calcemic hormones of IL-6 in stromal/ osteoblastic cells, Biochem Biophys Common 2000; 270: 1080-1085.
36. Lee YM, Kim SS, Kim HA et al. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 2003; 18: 97-102.